The Amgen Safety Net Foundation supports qualifying patients in the United States who might go without important medicines because of financial barriers.

Together with partners and stakeholders, we are working to overcome barriers that impede patient access to medicines and quality healthcare through a multifaceted approach focused on low-and middle-income countries and diseases with high unmet medical need.

In limited circumstances, Amgen provides continued or expanded access to its investigational products, as permitted by applicable law.

Making our products accessible through responsible pricing, patient support programs and targeted donation programs.